Technicals show distribution, not a compressed spring — price is below every short- and medium-term trend indicator with the 200 SMA as the only remaining support.

• Lower Bollinger band at 374.15
• $1 buffer to lower band
• Latest close 375.26
• Prior closes: 398.39, 390.65, 385.90, 376.77, 383.55, 375.93
• Sep-11 plunge volume: 7.48M shares (nearly double recent average)
• Four closes lower in last five sessions
• MACD line at -6.11
• MACD signal at -4.80
• MACD histogram at -1.31 (expanding lower)
• RSI at 36.96 (weak, not oversold; oversold is below 30)
• 10 EMA at 384
• 200 SMA at 349
• Stock down 6% over three months after 38% six-month rally
• Sep-15: UNH down 2.37% on a green tape day (stock-specific selling)
• Today volume 3.94M vs. 7.48M capitulation volume on Sep-11

↩ rebuts: “Bull claims lower Bollinger band, below 10 EMA, and MACD expansion are all 'bullish setups' — these are textbook distribution signals, not springs.”

Q2 EPS beat is base-effect illusion, not a V-shaped recovery — the company has stabilized at a structurally lower earnings plateau.

• Q4 2025 EPS was $0.01
• Revenue flat at ~$112B/quarter for four consecutive quarters
• TTM net margin 3.14% (vs. historical 5-6%)
• TTM operating margin 7.13% (vs. historical 8-9%)
• Commercial MLR running above 11% plan (per management/Trefis)
• Medicaid margins 'pressured through 2026' (management guidance)

↩ rebuts: “Bull's +61% YoY EPS growth comparison uses a near-zero Q4 2025 base — not a meaningful recovery signal.”

The 'fortress balance sheet' contains a $110B goodwill crater representing 36% of assets and 112% of stockholders' equity — one impairment away from wiping out ~2 quarters of FCF.

• Cash: $28.6B
• TTM FCF: $24.27B
• Q2 2026 FCF: $10.25B
• Q1 2026 FCF: $8.15B
• Q4 2025 FCF: $0.16B
• Goodwill: $110.65 billion
• Goodwill as % of total assets: 36%
• Goodwill as % of stockholders' equity: 112%
• A 10% impairment would equal $11 billion — roughly two quarters of FCF

↩ rebuts: “Bull touts $28.6B cash and $24.27B TTM FCF as fortress foundations while ignoring the $110.65B goodwill structural risk; annualizing Q2's $10.25B is a 'marketing trick' — TTM is the honest run-rate.”

Forward P/E 'discount' relies on $22.61 EPS estimates that may not deliver; in a hawkish-Fed environment, UNH historically compresses to 14-16x during MLR stress, not 18-19x.

• Forward P/E: 16.6x
• 5-year average forward P/E: 18-19x
• Forward EPS estimate: $22.61
• Polymarket prices 95% probability of zero Fed cuts in 2026

↩ rebuts: “Bull anchors on 18-19x historical average — that multiple was set during falling rates, stronger EPS growth, and GARP positioning; none of those conditions hold today.”

The 'wide moat' doesn't protect against simultaneous headwinds: commercial MLR above plan, Optum 'hitting a wall,' Medicaid pressure through 2026, and TPG partnership on Florida clinics indicating underperformance.

• CFO's 'blunt verdict': Optum 'hit a wall'
• TPG partnership on Florida clinics (tacit admission of underperformance)
• Commercial MLR above 11% plan
• Medicaid margins 'pressured through 2026'

↩ rebuts: “Bull invokes moat as a talisman — moats erode quietly via cost-line disappointments, Optum segment issues, and goodwill impairments one at a time.”

Hawkish-Fed is adverse to UNH specifically: higher rates squeeze employers/consumers → delayed care → sicker presentations → higher MLR, plus multiple compression for premium defensives.

• Commercial MLR goes UP under sticky inflation (rate-sensitive cost side)
• 10-year yields backing up (multiple-compression signal for premium defensives)
• Jamie Dimon publicly doubting 'we've slayed inflation' (hawkish signal)
• Polymarket prices 95% probability of zero Fed cuts in 2026

↩ rebuts: “Bull claims hawkish rates favor defensive compounders — but this generic thesis breaks down for UNH specifically because UNH's business is rate-sensitive on the cost side, not just the multiple side.”

All eight bull 'green flags' have critical flaws: long-term trend is thin (7.4% above 200 SMA), forward earnings beat is base-effect, goodwill is a structural risk, FCF is annualized, RSI is not oversold, moat doesn't prevent impairment, PE sale is triage, and valuation discount assumes estimates hold.

• 7.4% above 200 SMA after 6% 3-month pullback (thin buffer)
• Q2 beat vs. $0.01 Q4 2025 base (not clean recovery)
• $110B goodwill (36% of assets, 112% of equity)
• TTM FCF $24.27B, not $41B annualized
• RSI 36.96 (NOT oversold; oversold is below 30)
• TPG deal = triage, not management discipline
• Forward discount only valid if $22.61 EPS delivers

↩ rebuts: “Bull presents eight green flags — bear identifies zero clean flags, only flags with asterisks.”

Q3 catalyst calendar is a minefield of binary risks: Q3 earnings (MLR resolution), MA Final Rate Notice, and Oct-1 prior-authorization removal (MLR-negative utilization headwind).

• Q3 print will reveal MLR stabilization or worsening
• If MLR prints above 11% again, stock breaks 374 and heads toward 200 SMA at 349 (7% downside)
• MA Final Rate Notice is binary (UBS says 'unlikely to change' — UBS is paid to be reassuring)
• Oct-1 prior-authorization removal is MLR-negative (more services used = higher costs)

↩ rebuts: “Bull calls Q3 earnings the 'catalyst' — bear sees it as a binary event with asymmetric downside risk and no monetary tailwind to save the multiple.”

The tape is confirming distribution: stock-specific selling on green days, retail silence on WSB, momentum fading, and below-average volume indicating lack of buyer conviction.

• Sep-15: UNH down 2.37% on a green tape day (smart money rotating out)
• Zero discussion across WSB and investing forums for a mega-cap with 38% six-month rally
• Stock down 6% over three months after 38% six-month rally (momentum fading)
• Volume 3.94M today vs. 7.48M Sep-11 capitulation volume (lack of buyer conviction, not selling exhaustion)

↩ rebuts: “Bull interprets quiet tape as 'accumulation' — bear sees it as lack of conviction on either side, with smart money clearly rotating out on stock-specific weakness.”